Craneware plc 44.7% potential upside indicated by Berenberg Bank

Craneware plc with ticker (LON:CRW) now has a potential upside of 44.7% according to Berenberg Bank.



Berenberg Bank set a target price of 2,300 GBX for the company, which when compared to the Craneware plc share price of 1,590 GBX at opening today (19/09/2023) indicates a potential upside of 44.7%. Trading has ranged between 1,060 (52 week low) and 2,250 (52 week high) with an average of 62,074 shares exchanging hands daily. The market capitalisation at the time of writing is £555,795,219.

Craneware plc is a United Kingdom company that is engaged in the development, licensing, and ongoing support of computer software for the United States healthcare industry. Its value cycle insights are delivered through its Trisus platform for revenue integrity and 340B management, as well as margin and operational intelligence. Its applications and team of experts contextualize operational, financial, and clinical data, providing insights that clearly demonstrate realistic revenue integrity and 340B compliance opportunities for its customers. Its solutions include Trisus Pricing Transparency, Trisus Pricing Analyzer, Trisus Chargemaster, Insight Medical Necessity, Trisus Claims Informatics, Trisus Supply, Appeals Services, Trisus Healthcare Intelligence, Trisus Supplies Assistant, Trisus Medication Analytic Solutions, Sentinel, Sentrex, Sentrex 330, Referral Verification System (Sentrex), Referral Verification System (Senturion), Sentry Core, Senturion Professional Service and others.